abs267.txt	background		women	with	hiv	face	an	increased	risk	of	human	papillomavirus	(hpv)acquisition	and	persistence	cervical	intraepithelial	neoplasia	invasivecervical	cancer	our	objective	was	to	determine	the	cost-effectiveness	ofdifferent	screening	strategies	among	in	southafrica	methods	we	modified	a	mathematical	model	hpv	infection	diseaseto	reflect	coinfection	calibrated	epidemiologic	datafrom	hiv-infected	south	africa	clinical	economic	data	were	drawnfrom	in-country	sources	used	project	reductions	thelifetime	incremental	ratios(icers)	pap	dna	management	algorithms	beginning	at	hivdiagnosis	1-	2-	or	3-year	intervals	icer	below	southafrica's	2016	per	capita	gross	domestic	product	(us$5270)	considered	cost-effective	results	testing	followed	by	treatment	(test-and-treat)	2-year	intervalswas	most	effective	strategy	that	also	reducing	lifetimecancer	56	6%	us$3010	year	life	saved	othercost-effective	included	(referral	threshold	hsil+)	and3-year	test-and-treat	(ascus+)	hpvtesting	16/18	genotyping	visual	triage	ofhpv-positive	less	more	costly	than	alternatives	conclusions	considering	as	benchmark	forcost-effectiveness	is	optimal	lowercost-effectiveness	benchmarks	(hsil+)	would	be
